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Abstract
Background: CHARGE syndrome (CS) is a rare genetic condition (OMIM #214800). The condition has a variable
phenotypic expression. Historically, the diagnosis of CHARGE syndrome was based on the presence of specific
clinical criteria. The genetic aetiology of CS has since been elucidated and attributed to pathogenic variation in the
CHD7 gene (OMIM 608892) at chromosome locus 8q12.
Case presentation: A South African female of mixed ancestry heritage, aged 4 years, was referred for dental
assessment to the Faculty of Dentistry, University of the Western Cape, in 2018. She had a diagnosis of CHARGE
syndrome confirmed by a Medical Geneticist from the Division of Molecular Biology and Human Genetics at the
University of Stellenbosch.
The patient had a long prior history of health and developmental problems, with the correct diagnosis becoming
apparent over time. She presented with many oral and craniofacial features warranting consideration by the dentist
including micrognathia, hypoplastic nasal bones, cranial nerve dysfunction, bruxism, craniofacial anomalies and
compromised sensory perception. The treatment was mainly preventive and, although she fed through a
percutaneous endoscopic gastrostomy tube (PEG), maintenance of her oral hygiene was necessitated.
Conclusion: CS is a multisystem condition and the optimal care for an individual is with a specialist
multidisciplinary team. The numerous systemic problems affecting these individuals take precedence in their care,
and often there is neglect of their dental concerns. Given the abnormalities frequently present in the oral and
craniofacial region, the authors recommend that a team of dental and other medical specialists be involved in the
management of individuals with CS.
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Background
The purpose of this article was to review the genetic as-
pects and dental management challenges of CHARGE
syndrome (CS) (OMIM #214800). The history, genetic
background, clinical diagnostic criteria of CS are delin-
eated and a case report is presented. The acronym
“CHARGE” refers to Coloboma, Heart defect, Atresia
choanae, Retarded growth and development, Genital hy-
poplasia, Ear anomalies/deafness.
Charge syndrome is a rare genetic disorder in which
coloboma, choanal atresia or stenosis, cranial nerve dys-
function or anomaly and characteristic ear (external,
middle or inner ear) are the major features [1]. Multiple
anomalies affecting various organs systems including the
cardiovascular and genitourinary systems contribute to
the challenging medical management of affected persons
[2]. The debilitating general health effects of CHARGE
syndrome may be compounded by impairment in
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cognitive or intellectual functioning, feeding adaptation
and behavioural challenges [3].. CHARGE syndrome is a
rare genetic condition with an incidence of 1:12,000–15,
000 live births [4]. Historically, the diagnosis of
CHARGE syndrome was based on the presence of spe-
cific clinical criteria [5].
The acronym CHARGE was conferred by Pagon
et al.(1981) [6] to describe important clinical features:
Coloboma of the eye globe, Heart defects, Atresia of the
nasal choanae, Retardation of growth and development,
Genitourinary anomalies, and external Ear abnormalities
and/or associated hearing loss.
It is now understood that the CHARGE acronym pro-
vides an inadequate description of CS. Current clinical cri-
teria rely on the presence of a combination of major and
minor features, with the major features being more specific
for CS. The most accepted criteria are those described by
Blake et al. (1998) [7] and shown in Table 1. Depending on
the number of criteria identified, either a definite or a prob-
able/possible diagnosis of CS may be assigned.
The genetic aetiology of CS has since been elucidated
and attributed to pathogenic variation in the CHD7 gene
(OMIM 608892) at chromosome locus 8q12 [7].
The CHD7 gene is involved in control of gene expres-
sion, particularly chromatin remodelling.
Changes in the CHD7 gene sequence which lead to
absent or reduced protein result in disrupted chromatin
remodelling, ultimately leading to the multi-organ ab-
normalities found in CS [8]. CHD7 seems to be particu-
larly important in controlling the function of neural
crest cells, which are pluripotent cells with migratory
potential [9]. The neural crest has multiple vertebrate
derivatives, including the craniofacial skeleton, the cen-
tral nervous system (CNS) and associated sensory or-
gans, and parts of the heart. The induction of the neural
crest is determined by signalling molecules such as
BMP, WNT, FGF and retinoic acid [1, 10, 11]. The
process is controlled by a regulatory network of genes
including CHD7. Disruption of neural crest development
can result in several human disorders known as neuro-
cristopathies including those seen in CS [9].
It has overlapping features with other neurocristopa-
thies such as 22q11.2 deletion syndrome (also known as
DiGeorge syndrome or velocardiofacial syndrome) and
Kabuki syndrome, which are important differential diag-
noses [4]. Use of molecular genetic testing allows less
typical cases of CS to be diagnosed and has broadened
the phenotypic range of the condition.
The phenotype of CS is variable, with a wide range of
possible clinical problems and affected organ systems
[10]. Choanal atresia or stenosis causes breathing diffi-
culty that may be life-threatening in the newborn period
if both nasal passages are obstructed [12]. Ocular colo-
boma may cause visual deficit or blindness. Ear or ves-
tibular nerve effects may impact on hearing and/or
balance [4]. Other cranial nerve involvement may result
in anosmia, abnormal facial expression, and difficulties
with feeding and swallowing [13].
There may also be a range of less specific effects.
These include congenital heart defects, failure to thrive,
delayed development, delayed puberty, tracheoesopha-
geal fistula, kidney abnormalities; disorders of the
immune system; scoliosis and limb anomalies may ac-
company the disorder facial asymmetry and cleft palate
[13]. However, not all individuals are affected by intellec-
tual disability, the changes in sight, hearing and/or
speech may cause significant learning problems and spe-
cial needs.
In view of the wide range of organ systems involved, a
multidisciplinary approach to management of affected
children is necessary [14]. The pattern of congenital
malformations and the specific health problems differ
amongst affected individuals. For these reasons, we de-
scribe the management of a patient with CS, with par-
ticular refers to the oral and dental features.
Case presentation
A South African female of mixed ancestry heritage, aged
4 years, was referred to the Faculty of Dentistry, Univer-
sity of the Western Cape, for dental assessment in 2018.
A diagnosis of CHARGE syndrome was confirmed by a
Medical Geneticist from the Division of Molecular
Table 1 Blake criteria for the diagnosis of CHARGE syndrome
Major criteria Minor criteria
• Ocular coloboma
• Choanal atresia or stenosis
• Cranial nerve dysfunction or anomaly





• Cleft lip and/or palate
• Distinctive facial features
Definitive diagnosis of CHARGE syndrome:
• 4 major features OR
• 3 Major and 3 minor features
Probable/possible diagnosis of CHARGE syndrome:
• 1–2 major features and several minor features
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The patient had a lengthy history of health and develop-
mental problems, with the correct diagnosis becoming
apparent over time. She was the second child of a
healthy non-consanguineous couple. The pregnancy was
uneventful and without teratogen exposure. The fetal
anatomy scan at 18–22 weeks was missed, but at 36
weeks’ gestation, the sonographic findings included:
micrognathia, hypoplastic nasal bone, right renal agene-
sis and polyhydramnios. Prenatal genetic testing for an-
euploidies and 22q11.2 deletion was negative, and a
working diagnosis of ‘multiple congenital anomalies’ was
proposed.
Neonatal course
She was born normally at 37 weeks’, with birth weight of
2980 g (25th centile), length of 45 cm (3-10th) and head
circumference of 36 cm (90-97th). In addition to the pre-
natal features, she had midface hypoplasia and bilateral
ear anomalies (protruding ears, absent lobules). She
needed mechanical ventilation from birth and remained
in the intensive care unit for 5 months. At 3 months, a
tracheostomy was performed for upper airway obstruc-
tion, resulting from midface hypoplasia. She could nei-
ther breastfeed nor bottle-feed, and a PEG was inserted
at 4 months.
The girl had limited mouth movements, but an expres-
sionless face. She was unable to suck or swallow, and
when oral feeding was attempted, she aspirated feed into
her tracheostomy tube. There was minimal drooling. A
speech and feeding therapist supervised a period of oral
stimulation, but her sucking and swallowing reflexes did
not improve. Together, the findings indicated that she
had bilateral palsies of cranial nerves 7, 9 and 10. Feed-
ing remained entirely via the PEG, although she occa-
sionally liked to taste food by dabbing it on her tongue.
Despite careful attention to diet, her growth decelerated
postnatally, and all growth parameters clustered around
the 3rd centile.
The eyes were normal externally, but an optic disc
coloboma was detected. Audiological assessment indi-
cated that she could localise sound but she required
treatment for glue ear with grommets. Despite her pro-
longed health problems, her motor milestones pro-
gressed well - by 9 months of age she had a 2-month
deficit.
Her parents described her as a quiet child who had a
good relationship with her elder sibling and other chil-
dren. At examination, she remained unable to talk,
though this may have been a reflection of articulation
difficulties resulting from cranial nerve palsies and the
tracheostomy. She communicated quite well through
gestures and understood verbal comments. The patient
did not receive any chronic medication but was recalled
monthly to evaluate the patency of the PEG. Further-
more, she received antibiotic prophylaxis before any
invasive procedure. Currently, she is managed by a
multidisciplinary team which includes; occupational
therapist, speech/feeding therapist, dietician, ophthal-
mologist, ENT surgeon, pulmonologist, neurodevelop-
mental paediatrician,medical geneticist and a dental
team.
Neonatal investigations and diagnosis
During the neonatal period, a chromosomal microarray
showed no significant deletions or duplications of
chromosomal material. However, an MRI brain scan
showed non-specific changes consistent with ‘brain
shrinkage’.
A radiological contrast study at 3 months, indicated
that the patient was completely unable to swallow liq-
uids placed in the mouth, however, there was normal
peristalsis of contrast material injected into the
oesophagus. Additional studies showed that dye in the
mouth was aspirated into the trachea, but that there was
no evidence of gastro-oesophageal reflux.
Based on clinical and investigation findings, the patient
met the clinical criteria for a diagnosis of CHARGE syn-
drome. The clinical diagnosis was corroborated by mo-
lecular investigations: sequencing of the CHD7 gene
showed a heterozygous pathogenic variant c.1977delC
(p. Lys660Argfs*51).
Facial and dental assessment
The main dental complaint was bruxism, and her par-
ents reported that they can hear her grind her teeth at
night. Her oral hygiene was poor as her mother wiped
her mouth once every morning using a gauze and saline.
On examination, the patient has square shaped face,
with mid-facial hypoplasia indicated by malar flatness
and a small nose with anteverted nostrils. Her lips were
incompetent with a short philtrum (Fig. 1). The bilateral
lower motor neuron facial nerve palsy resulted in the in-
ability to display any facial expressions. She had marked
micrognathia with a tracheostomy device in-situ, and
had bilaterally protruding ears which lacked lobules
(Fig. 2). The shape of the face and appearance of the ears
are typical of CHARGE syndrome.
The child was co-operative and sat in the dental chair
without any resistance. She understood instructions but
was unable to open her mouth adequately for extensive
examination and intra-oral clinical photographs and she
did not tolerate certain dental instruments placed in her
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mouth. It was difficult to gauge the strength of her
mouth opening.
All primary teeth were present. Although she had poor
oral hygiene,visible plaque and generalized mild to mod-
erate gingival hyperplasia, she was caires – free. The in-
cisal edge of her anterior incisor was chipped and there
was fusion of her 81 and 82 teeth (Fig. 3). Mild occlusal
wear on her posterior teeth was evident, consistent with
her bruxing habit. Normal frenal attachment.
Dental treatment
The treatment is mainly preventive at this stage and,
although she feeds through a PEG tube, her oral hygiene
must be maintained to prevent caries and other
pathology.
Oral hygiene education was provided to the mother
who was advised to brush the child’s teeth twice a day
using a soft age-appropriate toothbrush. A simple rub-
bing technique was demonstrated. A smear layer of
toothpaste was advised according to the American Acad-
emy of Pediatric Dentistry guidelines [15]. Also, the use
of floss if possible between tight contacts in her teeth.
Fluoride was applied on the second visit; an applica-
tion of 5% sodium fluoride (Clinpro white) varnish using
a small brush. The application of fluoride in accordance
with the standard protocol of the institution, because of
the high caries prevalence in the demographic area. This
is usually attributed to poor oral hygiene practices and
Fig. 1 Patient has square shaped face, with mid-facial hypoplasia.
Her lips were incompetent with a short philtrum
Fig. 2 She had marked micrognathia with a tracheostomy device in-
situ, and had bilaterally protruding ears that lacked lobules
Fig. 3 Plaque accumulation and generalized mild to moderate
gingival hyperplasia is evident. The incisal edge of her anterior
incisor was chipped and there was fusion of her 81 and 82
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cariogenic diets of children routinely visiting the dental
clinics at the Faculty of Dentistry, UWC. Furthermore,
this patient was regarded as a “high risk” candidate for
dental caries.
All intraoral examinations using only a mouth mir-
ror were tolerated fleetingly. Ideally, a bite-plate
would prevent her bruxism and inhibit excessive
forces from being exerted on her temporomandibular
joint. However, considering her general health condi-
tions associated to her stage of development, she was
unable to tolerate impression material in her mouth
and it was decided that if deemed necessary, future
dental management will be discussed with a multi-
disciplinary dental team after eruption of her perman-
ent teeth. Dental follow-up at 6 monthly intervals was
arranged.
Discussion
Using the Blake criteria (1998) [7], the patient had three
major features and three minor features of CS. The
major features were ocular coloboma, characteristic ex-
ternal ear, and cranial nerve dysfunction. The minor fea-
tures were developmental delay, growth retardation and
characteristic face. This allowed a clinical diagnosis of
‘definite CHARGE syndrome’.
The clinical diagnosis was later confirmed by genetic
testing. A heterozygous variant in the CHD7 gene was
isolated. Since CS results from pathogenic variant in a
single copy of CHD7, and the CHD7 gene is located on
a non-sex chromosome, the inheritance pattern is auto-
somal dominant. In this instance, as in most cases of CS,
there was no family history. This is because the CHD7
mutation usually arises de novo in the affected individ-
ual, which also means that there is a low recurrence risk
in a next pregnancy [16].
Oral health professionals treating children with CS
syndrome should be mindful of the several systemic ab-
normalities associated with the condition as well as
other potential challenges, which may influence dental
care.
Dental anomalies found in CS
Dental anomalies seen in CS are those of the shape of
teeth includings taurodontism and anomalies of tooth
number for example hypodontia and supernumerary
teeth. Agenesis, malformations and ectopic eruption of
the anterior teeth, in particular, could result in difficultly
with phonation and tongue co-ordination. However, the
low incidence of this syndrome makes it difficult to de-
lineate a comprehensive dental picture [17]. The dental
features reported in the literature were not evident in
our patient.
Challenges in the dental environment
Cranial nerve abnormalities
The patient presented many oral and craniofacial
features warranting consideration by the dentist. Of
particular clinical importance is the involvement of
several cranial nerves. The most common cranial
nerve abnormalities are those of cranial nerves V, VII,
IX, X and XI [13]. In our patient, the trigeminal
nerve (V) was not obviously involved. The nerve in-
nervates the muscles of mastication and provides taste
to the anterior two thirds of the tongue. Our patient’s
ability to taste was preserved and she had limited
mouth opening. Her ability to chew could not be
assessed, but bruxism may be an indication that the
muscles of mastication was strong.
Our patient’s inability to swallow or to protect her air-
way may have been the result of involvement of the
glossopharyngeal (IX) and vagus (X) nerves. The associ-
ation between CS,feeding difficulties and poor growth is
well-documented [4, 13, 16]. Recently it has been docu-
mented that cranial nerve dysfunction was the primary
clinical feature contributing to feeding difficulties the CS
that may result in inadequate sucking, chewing and
swallowing and aspiration [18]. Consequently, the pres-
ence of these problems in infancy may predict long-term
feeding problems that warrants the continuous assist-
ance of a feeding specialist.
Swallowing is a complex, coordinated sequence of
activation of over 25 pairs of muscles in the mouth
pharynx and oesophagus that is controlled by vagus
nerve [19]. The swallowing process protects the airway
from aspiration of the food bolus. Defective swallow-
ing in children with CS impede the protection of the
airways. For this reason, oral health care workers are
cautioned about the possibility of of choking or aspir-
ation of dental material and the risk of anaesthesia-
related complications [10]. Blake et al.(2009) [20]
assessed 147 anaesthetic events for children with CS
and found a 35% incidence of post-operative airways
events, 4% of which were for dental procedures. They
recommended combining multiple procedures under
one anaesthetic wherever possible, as this did not
increase the per-procedure risk of post-operative
complications.
Bruxism
Bruxism is known to occur in CS. Inchingolo et al.
(2014) [17] reported constant nighttime bruxism in at
least two of seven cases. Young children self-stimulate in
order to learn about their bodies and the environment.
This need is more intense in children with multisensory
impairment, a fact which may be relevant to the devel-
opment of bruxism in CS [21].
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Sensory perception
The effects of CS on organs of sensory perception and
communication are important for a dental practitioner.
Problems with sensory receptors of the eye, the ear, and
frequently also the vestibular apparatus may make func-
tioning for the affected individuals very challenging, es-
pecially where severe combined deficits of balance,
hearing and vision impact on motor skills and communi-
cation [21]. Within the realms of dentistry, appropriate
therapy would necessitate close collaboration with ‘deaf-
blind’ specialists [22].
In our patient balance was normal, and vision and
hearing not severely affected. However, communication
was hampered by lack of facial expression and lack of
speech, both expected to be permanent. Although plastic
surgery techniques may cosmetically improve facial ex-
pression, this may not be crucial since our patient does
not drool and effectively uses gestures to convey emo-
tion. While 75% of patients with CS have intellectual dis-
ability, in this patient the lack of speech may relate to
articulation rather than intellectual difficulties. Assess-
ment by a neurodevelopmental paediatrician is essential,
both to determine intellectual potential and to consider
the role of alternative communication methods, for ex-
ample using specific sign language or assisted communi-
cation devices.
Cognitive function
If there is impaired cognitive function, the effects on be-
haviour need to be considered. There may be very goal
directed and persistent behaviour, which often increases
under stress. In addition, self-regulation may be poor,
with easy loss of behavioural control and difficulty shift-
ing attention and moving onto new things. The anticipa-
tion of pain may lead to elevated levels of anxiety which
can result in lowered tolerance to pain [23]. These fac-
tors need to be taken into account during dental exam-
ination and therapies. It may require therapies to be
adjusted and guide dental surveillance on potential fu-
ture dental needs.
Craniofacial anomalies
A number of other oral and dental features of CS have
been previously described [17]. There is a short upper
lip, with lip incompetence and oral breathing. In a retro-
spective study between 1998 and 2016, Isaac et al. (2017)
[24] reported that 11 of 44 patients with CS presented
with a cleft of either the lip, palate or both. Infants with
CS and clefts is at an increased risk for feeding difficulty
and speech. Furthermore, breathing may be obstructed
by unilateral or bilateral choanal atresia.
Cranio-cervical junction abnormalities are common in
CS [24]. These are demonstrated by a high prevalence of
basioccipital hypoplasia and basilar invagination. Careful
manipulation of the head during dental management is
necessary in order to prevent possible life-threatening
consequences of basilar invagination.
Allergies
Kong and Martin (2018) [25] a high percentage of aller-
gies in individuals with CS (approximately 48%). The al-
lergens included food and drugs and manifested in
contact allergies, rhinitis and asthma. In dental context,
the use of gloves and dental materials may initiate atopic
reactions in patients with CS and cautioned is required
when treating them.
Conclusion
The dental and craniofacial anomalies often present in
CS result in breathing and swallowing difficulties, peri-
odontal disease due to poor oral hygiene and the trau-
matic stimulation of bruxism, and the lack of co-
ordination and paralysis of the facial musculature. Den-
tofacial orthopaedics maybe delayed in patients who are
medically unstable.
CS is a multisystem condition and the optimal care for
an individual is with a specialist multidisciplinary team.
The multiple systemic problems affecting these individ-
uals take precedence in their care, and often there is
neglect of their dental concerns. Given the abnormalities
frequently present in the oral and craniofacial region,
the authors recommend that a team of dental and other
medical specialists be involved in the management of in-
dividuals with CS. The dental practitioner, as part of this
multidisciplinary team, can add value to the care and
quality of life of individuals with CS, but must also
mindful of the potential risks associated with such care,
for example related to anaesthesia. This case report con-
tributes to the limited published information on the den-
tal concerns in this genetic condition and highlights the
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